Idexx Laboratories | IDXX - Selling And Administration Expenses


Idexx Laboratories reported $299.85M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Accuray USD 124.78M 2.54M Dec/2025
Align Technology USD 465.34M 23.67M Mar/2026
AngioDynamics USD 36.57M 3.79M Sep/2025
Dentsply International USD 351M 32M Mar/2026
Dexcom USD 349.7M 49.8M Mar/2026
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Fujifilm JPY 236.14B 20.3B Mar/2026
Globus Medical USD 297.77M 20.7M Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
Masimo USD 143.4M 15.4M Mar/2026
Neogen USD 98.5M 9M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
ResMed USD 279.8M 1.4M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Steris USD 351.8M 500K Mar/2026
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 226.01M 3.64M Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Zoetis USD 588M 31M Mar/2026